Cancer Research Meeting Calendar Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boland, A.
Right arrow Articles by Perricaudet, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boland, A.
Right arrow Articles by Perricaudet, M.
[Cancer Research 60, 3484-3492, July 1, 2000]
© 2000 American Association for Cancer Research

Experimental Therapeutics

Adenovirus-mediated Transfer of the Thyroid Sodium/Iodide Symporter Gene into Tumors for a Targeted Radiotherapy1

Anne Boland2, Marcel Ricard, Paule Opolon, Jean-Michel Bidart, Patrice Yeh, Sebastiano Filetti, Martin Schlumberger and Michel Perricaudet

UMR1582 CNRS-IGR-Rhône-Poulenc [A. B., P. O., P. Y., M. P.] and Service de Physique [M. R.], Département de Biologie Clinique [J-M. B.], and Service de Médecine Nucléaire [M. S.], Institut Gustave Roussy [M. S.], 94805 Villejuif, France, and Dipartimento di Medicina Sperimentale e Clinica, Università di Catnzaro, 88100 Catanzaro, Italy [S. F.]

The Na+/I- symporter (NIS) present in the membranes of thyroid cells is responsible for the capacity of the thyroid to concentrate iodide. This allows treatment of thyroid cancers with 131I. We propose to enlarge this therapeutic strategy to nonthyroid tumors by using an adenoviral vector to deliver the NIS gene into the tumor cells. We constructed a recombinant adenovirus encoding the rat NIS gene under the control of the cytomegalovirus promoter (AdNIS). Infection of SiHa cells (human cervix tumor cells) with AdNIS resulted in perchlorate-sensitive 125I uptake by these cells to a level 125–225 times higher than that in noninfected cells. Similar results were obtained for other human tumor cell lines, including MCF7 and T-47D (mammary gland), DU 145 and PC-3 (prostate), A549 (lung), and HT-29 (colon), demonstrating that the AdNIS vector can function in tumor cells of various origins. In addition, AdNIS-infected tumor cells were selectively killed by exposure to 131I, as revealed by clonogenic assays. To assess the efficiency of this cancer gene therapy strategy in vivo, we injected the AdNIS vector in human tumors (SiHa or MCF7 cells) established s.c. in nude mice. Immunohistological analysis confirmed the expression of the NIS protein in the tumor. Three days after intratumoral injection, AdNIS-treated tumors could specifically accumulate 125I or 123I, as revealed by kinetics and imaging experiments. A quantitative analysis demonstrated that the uptake in AdNIS-injected tumors was 4–25 times higher than that in nontreated tumors. On average, 11% of the total amount of injected 125I could be recovered per gram of AdNIS-treated tumor tissue. Altogether, these data indicate that AdNIS is very efficient in triggering significant iodide uptake by a tumor, outlining the potential of this novel cancer gene therapy approach for a targeted radiotherapy.




This article has been cited by other articles:


Home page
 Anticancer ResHome page
R.-S. LIU, Y.-J. HSIEH, C.-C. KE, F.-D. CHEN, L. HWU, F.-H. WANG, J.-J. HWANG, C.-W. CHI, C.-H. LEE, and S.-H. YEH
Specific Activation of Sodium Iodide Symporter Gene in Hepatoma Using Alpha-fetoprotein Promoter Combined with Hepatitis B Virus Enhancer (EIIAPA)
Anticancer Res, January 1, 2009; 29(1): 211 - 221.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Peerlinck, S. Amini-Nik, R. K. Phillips, R. Iggo, N. R. Lemoine, S. Tejpar, and G. Vassaux
Therapeutic Potential of Replication-Selective Oncolytic Adenoviruses on Cells from Familial and Sporadic Desmoid Tumors
Clin. Cancer Res., October 1, 2008; 14(19): 6187 - 6192.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S.-Y. Park, W. Kwak, N. Tapha, M.-Y. Jung, J.-O. Nam, I.-S. So, S.-Y. Kim, J. Yoo, J. Lee, and I.-S. Kim
Combination Therapy and Noninvasive Imaging with a Dual Therapeutic Vector Expressing MDR1 Short Hairpin RNA and a Sodium Iodide Symporter
J. Nucl. Med., September 1, 2008; 49(9): 1480 - 1488.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Goel, S. K. Carlson, K. L. Classic, S. Greiner, S. Naik, A. T. Power, J. C. Bell, and S. J. Russell
Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV({Delta}51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene
Blood, October 1, 2007; 110(7): 2342 - 2350.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. J. Lim, J. C. Paeng, S. J. Kim, S. Y. Kim, H. Lee, and D. H. Moon
Enhanced Expression of Adenovirus-Mediated Sodium Iodide Symporter Gene in MCF-7 Breast Cancer Cells with Retinoic Acid Treatment
J. Nucl. Med., March 1, 2007; 48(3): 398 - 404.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K.-H. Lee, J.-S. Bae, S.-C. Lee, J.-Y. Paik, T. Matsui, K.-H. Jung, B.-H. Ko, and B.-T. Kim
Evidence that Myocardial Na/I Symporter Gene Imaging Does Not Perturb Cardiac Function
J. Nucl. Med., November 1, 2006; 47(11): 1851 - 1857.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
G. Riesco-Eizaguirre and P. Santisteban
A perspective view of sodium iodide symporter research and its clinical implications.
Eur. J. Endocrinol., October 1, 2006; 155(4): 495 - 512.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Hasegawa, L. Pham, M. K. O'Connor, M. J. Federspiel, S. J. Russell, and K.-W. Peng
Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
Clin. Cancer Res., March 15, 2006; 12(6): 1868 - 1875.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Petrich, L. Quintanilla-Martinez, Z. Korkmaz, E. Samson, H. J. Helmeke, G. J. Meyer, W. H. Knapp, and E. Potter
Effective Cancer Therapy with the {alpha}-Particle Emitter [211At]Astatine in a Mouse Model of Genetically Modified Sodium/Iodide Symporter-Expressing Tumors
Clin. Cancer Res., February 15, 2006; 12(4): 1342 - 1348.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. D. Vadysirisack, D. H. Shen, and S. M. Jhiang
Correlation of Na+/I- Symporter Expression and Activity: Implications of Na+/I- Symporter as an Imaging Reporter Gene
J. Nucl. Med., January 1, 2006; 47(1): 182 - 190.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Z. Zhang, Y.-Y. Liu, and S. M. Jhiang
Cell Surface Targeting Accounts for the Difference in Iodide Uptake Activity between Human Na+/I- Symporter and Rat Na+/I- Symporter
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6131 - 6140.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Cengic, C. H. Baker, M. Schutz, B. Goke, J. C. Morris, and C. Spitzweg
A Novel Therapeutic Strategy for Medullary Thyroid Cancer Based on Radioiodine Therapy following Tissue-Specific Sodium Iodide Symporter Gene Expression
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4457 - 4464.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K.-H. Lee, H.-K. Kim, J.-Y. Paik, T. Matsui, Y. S. Choe, Y. Choi, and B.-T. Kim
Accuracy of Myocardial Sodium/Iodide Symporter Gene Expression Imaging with Radioiodide: Evaluation with a Dual-Gene Adenovirus Vector
J. Nucl. Med., April 1, 2005; 46(4): 652 - 657.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. M. Dwyer, E. R. Bergert, M. K. O'Connor, S. J. Gendler, and J. C. Morris
In vivo Radioiodide Imaging and Treatment of Breast Cancer Xenografts after MUC1-Driven Expression of the Sodium Iodide Symporter
Clin. Cancer Res., February 15, 2005; 11(4): 1483 - 1489.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. I. Kim, J.-K. Chung, J. H. Kang, Y. J. Lee, J. H. Shin, H. J. Oh, J. M. Jeong, D. S. Lee, and M. C. Lee
Visualization of Endogenous p53-Mediated Transcription In vivo Using Sodium Iodide Symporter
Clin. Cancer Res., January 1, 2005; 11(1): 123 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Miyagawa, M. Beyer, B. Wagner, M. Anton, C. Spitzweg, B. Gansbacher, M. Schwaiger, and F. M. Bengel
Cardiac reporter gene imaging using the human sodium/iodide symporter gene
Cardiovasc Res, January 1, 2005; 65(1): 195 - 202.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Faivre, J. Clerc, R. Gerolami, J. Herve, M. Longuet, B. Liu, J. Roux, F. Moal, M. Perricaudet, and C. Brechot
Long-Term Radioiodine Retention and Regression of Liver Cancer after Sodium Iodide Symporter Gene Transfer in Wistar Rats
Cancer Res., November 1, 2004; 64(21): 8045 - 8051.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Mitrofanova, R. Unfer, N. Vahanian, W. Daniels, E. Roberson, T. Seregina, P. Seth, and C. Link Jr.
Rat Sodium Iodide Symporter for Radioiodide Therapy of Cancer
Clin. Cancer Res., October 15, 2004; 10(20): 6969 - 6976.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. H. Kang, J.-K. Chung, Y. J. Lee, J. H. Shin, J. M. Jeong, D. S. Lee, and M. C. Lee
Establishment of a Human Hepatocellular Carcinoma Cell Line Highly Expressing Sodium Iodide Symporter for Radionuclide Gene Therapy
J. Nucl. Med., September 1, 2004; 45(9): 1571 - 1576.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. L. Wapnir, M. Goris, A. Yudd, O. Dohan, D. Adelman, K. Nowels, and N. Carrasco
The Na+/I- Symporter Mediates Iodide Uptake in Breast Cancer Metastases and Can Be Selectively Down-Regulated in the Thyroid
Clin. Cancer Res., July 1, 2004; 10(13): 4294 - 4302.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
U. Haberkorn, P. Beuter, W. Kubler, H. Eskerski, M. Eisenhut, R. Kinscherf, S. Zitzmann, L. G. Strauss, A. Dimitrakopoulou-Strauss, and A. Altmann
Iodide Kinetics and Dosimetry In Vivo After Transfer of the Human Sodium Iodide Symporter Gene in Rat Thyroid Carcinoma Cells
J. Nucl. Med., May 1, 2004; 45(5): 827 - 833.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. V. Scholz, N. Cengic, B. Goke, J. C. Morris, and C. Spitzweg
Dexamethasone Enhances the Cytotoxic Effect of Radioiodine Therapy in Prostate Cancer Cells Expressing the Sodium Iodide Symporter
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1108 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
G. Niu, A. W. Gaut, L. L. B. Ponto, R. D. Hichwa, M. T. Madsen, M. M. Graham, and F. E. Domann
Multimodality Noninvasive Imaging of Gene Transfer Using the Human Sodium Iodide Symporter
J. Nucl. Med., March 1, 2004; 45(3): 445 - 449.
[Abstract] [Full Text]

Home page
 JNMHome page
L. S. Zuckier, O. Dohan, Y. Li, C. J. Chang, N. Carrasco, and E. Dadachova
Kinetics of Perrhenate Uptake and Comparative Biodistribution of Perrhenate, Pertechnetate, and Iodide by NaI Symporter-Expressing Tissues In Vivo
J. Nucl. Med., March 1, 2004; 45(3): 500 - 507.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
L. Barzon, M. Boscaro, and G. Palu
Endocrine Aspects of Cancer Gene Therapy
Endocr. Rev., February 1, 2004; 25(1): 1 - 44.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Zhang, S. Sharma, L. X. Zhu, T. Kogai, J. M. Hershman, G. A. Brent, S. M. Dubinett, and M. Huang
Nonradioactive Iodide Effectively Induces Apoptosis in Genetically Modified Lung Cancer Cells
Cancer Res., August 15, 2003; 63(16): 5065 - 5072.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Spitzweg, I. V. Scholz, E. R. Bergert, D. J. Tindall, C. Y. F. Young, B. Goke, and J. C. Morris
Retinoic Acid-Induced Stimulation of Sodium Iodide Symporter Expression and Cytotoxicity of Radioiodine in Prostate Cancer Cells
Endocrinology, August 1, 2003; 144(8): 3423 - 3432.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. L. Wapnir, M. van de Rijn, K. Nowels, P. S. Amenta, K. Walton, K. Montgomery, R. S. Greco, O. Dohan, and N. Carrasco
Immunohistochemical Profile of the Sodium/Iodide Symporter in Thyroid, Breast, and Other Carcinomas Using High Density Tissue Microarrays and Conventional Sections
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1880 - 1888.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. L. Schipper, A. Weber, M. Behe, R. Goke, W. Joba, H. Schmidt, T. Bert, B. Simon, R. Arnold, A. E. Heufelder, et al.
Radioiodide Treatment after Sodium Iodide Symporter Gene Transfer Is a Highly Effective Therapy in Neuroendocrine Tumor Cells
Cancer Res., March 15, 2003; 63(6): 1333 - 1338.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
T. F. Massoud and S. S. Gambhir
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Genes & Dev., March 1, 2003; 17(5): 545 - 580.
[Full Text] [PDF]

Home page
 JNMHome page
J.-K. Chung
Sodium Iodide Symporter: Its Role in Nuclear Medicine
J. Nucl. Med., September 1, 2002; 43(9): 1188 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
K. R. Zinn, T. R. Chaudhuri, V. N. Krasnykh, D. J. Buchsbaum, N. Belousova, W. E. Grizzle, D. T. Curiel, and B. E. Rogers
Gamma Camera Dual Imaging with a Somatostatin Receptor and Thymidine Kinase after Gene Transfer with a Bicistronic Adenovirus in Mice
Radiology, March 21, 2002; (2002) 2232010501.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. A. Smit, J. P. Schroder-van der Elst, M. Karperien, I. Que, M. Stokkel, D. van der Heide, and J. A. Romijn
Iodide Kinetics and Experimental 131I Therapy in a Xenotransplanted Human Sodium-Iodide Symporter-Transfected Human Follicular Thyroid Carcinoma Cell Line
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1247 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
U. Haberkorn and A. Altmann
Imaging Techniques for Gene Therapy: SPECT, PET, and MRI
Journal of Pharmacy Practice, October 1, 2001; 14(5): 383 - 396.
[Abstract] [PDF]

Home page
 RadiologyHome page
A. Moore, L. Josephson, R. M. Bhorade, J. P. Basilion, and R. Weissleder
Human Transferrin Receptor Gene as a Marker Gene for MR Imaging
Radiology, October 1, 2001; 221(1): 244 - 250.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Spitzweg, K. J. Harrington, L. A. Pinke, R. G. Vile, and J. C. Morris
The Sodium Iodide Symporter and Its Potential Role in Cancer Therapy
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3327 - 3335.
[Full Text] [PDF]

Home page
 JNMHome page
L. S. Zuckier, E. Dadachova, O. Dohan, N. Carrasco, Y. Nakamoto, T. Saga, T. Misaki, and S. Kosugi
The Endogenous Mammary Gland Na+/I- Symporter May Mediate Effective Radioiodide Therapy in Breast Cancer
J. Nucl. Med., June 1, 2001; 42(6): 987 - 987.
[Full Text] [PDF]

Home page
 JNMHome page
J.-L. C. Urbain
Reporter Genes and Imagene
J. Nucl. Med., January 1, 2001; 42(1): 106 - 109.
[Full Text] [PDF]

Home page
 RadiologyHome page
K. R. Zinn, T. R. Chaudhuri, V. N. Krasnykh, D. J. Buchsbaum, N. Belousova, W. E. Grizzle, D. T. Curiel, and B. E. Rogers
Gamma Camera Dual Imaging with a Somatostatin Receptor and Thymidine Kinase after Gene Transfer with a Bicistronic Adenovirus in Mice
Radiology, May 1, 2002; 223(2): 417 - 425.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.